valproic acid has been researched along with Affective Disorders, Psychotic in 15 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Affective Disorders, Psychotic: Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.
Excerpt | Relevance | Reference |
---|---|---|
", who received at least 6 weeks of add-on olanzapine treatment for psychotic mood disorders (schizoaffective disorders [bipolar and depressive type], bipolar disorders [I, II, and NOS], and major depressive disorder)." | 5.09 | Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. ( Grace, JJ; Narendran, R; Pato, MT; Pristach, CA; Valenti, AM; Young, CM, 2001) |
"Many types of medicaments can cause akathisia as an adverse event of their use and they include: antipsychotics, antidepressants, antiemetics, antihistamines, and psychoactive substances." | 1.37 | Symptoms of agitated depression and/or akathisia. ( Blažević-Zelić, S; Peitl, MV; Peitl, V; Prološčić, J; Skarpa-Usmiani, I, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (40.00) | 18.7374 |
1990's | 5 (33.33) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Peitl, MV | 1 |
Prološčić, J | 1 |
Blažević-Zelić, S | 1 |
Skarpa-Usmiani, I | 1 |
Peitl, V | 1 |
Nakamura, M | 1 |
Salisbury, DF | 1 |
Hirayasu, Y | 1 |
Bouix, S | 1 |
Pohl, KM | 1 |
Yoshida, T | 1 |
Koo, MS | 1 |
Shenton, ME | 1 |
McCarley, RW | 1 |
Harter, C | 1 |
Obier, C | 1 |
Druschky, KF | 1 |
Eikelmann, B | 1 |
Emrich, HM | 5 |
Günther, R | 1 |
Dose, M | 1 |
von Zerssen, D | 4 |
Kissling, W | 3 |
Möller, HJ | 3 |
Windorfer, A | 1 |
Nizamie, SH | 1 |
Chatterjee, S | 1 |
Kando, JC | 1 |
Tohen, M | 1 |
Castillo, J | 1 |
Zarate, CA | 1 |
Narendran, R | 1 |
Young, CM | 1 |
Valenti, AM | 1 |
Pristach, CA | 1 |
Pato, MT | 1 |
Grace, JJ | 1 |
Mosolov, SN | 1 |
Kastner, T | 1 |
Friedman, DL | 1 |
Plummer, AT | 1 |
Ruiz, MQ | 1 |
Henning, D | 1 |
1 review available for valproic acid and Affective Disorders, Psychotic
Article | Year |
---|---|
Current perspectives in the pharmacopsychiatry of depression and mania.
Topics: Affective Disorders, Psychotic; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Endorp | 1983 |
4 trials available for valproic acid and Affective Disorders, Psychotic
Article | Year |
---|---|
Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Alcohol Withdrawal Delirium; Bipolar Disorder; Cl | 1980 |
Therapeutic effect of valproate in mania.
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Clinical Trials as Topic; Double-Blind Method; Hum | 1981 |
Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
Topics: Adult; Affective Disorders, Psychotic; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; | 2001 |
[Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses].
Topics: Adult; Affective Disorders, Psychotic; Aged; Carbamazepine; Humans; Lithium; Lithium Carbonate; Midd | 1991 |
10 other studies available for valproic acid and Affective Disorders, Psychotic
Article | Year |
---|---|
Symptoms of agitated depression and/or akathisia.
Topics: Affective Disorders, Psychotic; Akathisia, Drug-Induced; Anticonvulsants; Antidepressive Agents, Sec | 2011 |
Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Algorithms; Antimanic Agents; Antipsychotic Agent | 2007 |
[Malignant neuroleptic syndrome associated with amisulpride].
Topics: Affective Disorders, Psychotic; Amisulpride; Anticonvulsants; Antipsychotic Agents; Creatine Kinase; | 2008 |
New drugs for mania?
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Humans; Propranolol; Psychotic Disorders; Valproic | 1983 |
On a possible role of GABA in mania. Therapeutic efficacy of sodium valproate.
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Double-Blind Method; Drug Evaluation; gamma-Aminob | 1981 |
Affective psychosis in Eales' disease and response to sodium valproate.
Topics: Adult; Affective Disorders, Psychotic; Combined Modality Therapy; Electroconvulsive Therapy; Humans; | 1994 |
The use of valproate in an elderly population with affective symptoms.
Topics: Affective Disorders, Psychotic; Age Factors; Aged; Antimanic Agents; Comorbidity; Depressive Disorde | 1996 |
Valproate and mood disorders: perspectives. Summit conferences on the Treatment of Bipolar Disorders, July 27-28, 1990, Colorado Springs, Colorado and January 24-27, 1991, Snowmass, Colorado.
Topics: Affective Disorders, Psychotic; Humans; Valproic Acid | 1992 |
Valproic acid for the treatment of children with mental retardation and mood symptomatology.
Topics: Adolescent; Adolescent Behavior; Affective Disorders, Psychotic; Child; Child Behavior; Drug Evaluat | 1990 |
Emerging perspectives on valproate in affective disorders.
Topics: Affective Disorders, Psychotic; Humans; Valproic Acid | 1989 |